AP2185A - de, a process for its preparation and pharmaceuticDelta d crystalline form of ivabradine hydrochlorial compositions containing it. - Google Patents

de, a process for its preparation and pharmaceuticDelta d crystalline form of ivabradine hydrochlorial compositions containing it.

Info

Publication number
AP2185A
AP2185A AP2006003757A AP2006003757A AP2185A AP 2185 A AP2185 A AP 2185A AP 2006003757 A AP2006003757 A AP 2006003757A AP 2006003757 A AP2006003757 A AP 2006003757A AP 2185 A AP2185 A AP 2185A
Authority
AP
ARIPO
Prior art keywords
pharmaceuticdelta
hydrochlorial
ivabradine
preparation
crystalline form
Prior art date
Application number
AP2006003757A
Other languages
English (en)
Other versions
AP2006003757A0 (en
Inventor
Stephanie Horvath
Marie-Noelle Auguste
Gerard Damien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36588996&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2185(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2006003757A0 publication Critical patent/AP2006003757A0/xx
Application granted granted Critical
Publication of AP2185A publication Critical patent/AP2185A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2006003757A 2005-10-11 2006-09-27 de, a process for its preparation and pharmaceuticDelta d crystalline form of ivabradine hydrochlorial compositions containing it. AP2185A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0510354A FR2891827B1 (fr) 2005-10-11 2005-10-11 Forme cristalline deltad du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
AP2006003757A0 AP2006003757A0 (en) 2006-10-31
AP2185A true AP2185A (en) 2010-12-30

Family

ID=36588996

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003757A AP2185A (en) 2005-10-11 2006-09-27 de, a process for its preparation and pharmaceuticDelta d crystalline form of ivabradine hydrochlorial compositions containing it.

Country Status (32)

Country Link
US (3) US7384932B2 (xx)
EP (2) EP1958937A1 (xx)
JP (1) JP2007112797A (xx)
KR (1) KR20070040310A (xx)
CN (1) CN1948293A (xx)
AP (1) AP2185A (xx)
AR (1) AR056573A1 (xx)
AU (1) AU2006228028B2 (xx)
BR (1) BRPI0604253A (xx)
CA (1) CA2564369C (xx)
CO (1) CO5840253A1 (xx)
CR (1) CR8647A (xx)
EA (1) EA010286B1 (xx)
EC (1) ECSP066914A (xx)
FR (1) FR2891827B1 (xx)
GE (1) GEP20094654B (xx)
GT (1) GT200600448A (xx)
IL (1) IL178545A (xx)
MA (1) MA28625B1 (xx)
MX (1) MXPA06011767A (xx)
MY (1) MY140490A (xx)
NI (1) NI200600240A (xx)
NO (1) NO20064588L (xx)
NZ (1) NZ550436A (xx)
PE (1) PE20070547A1 (xx)
SA (1) SA06270371B1 (xx)
SG (1) SG131857A1 (xx)
TW (1) TW200800221A (xx)
UA (1) UA90266C2 (xx)
UY (1) UY29856A1 (xx)
WO (1) WO2007042657A1 (xx)
ZA (1) ZA200608404B (xx)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP2097383B1 (en) 2006-11-30 2012-02-08 Cadila Healthcare Limited Process for preparation of ivabradine hydrochloride
CN101353325B (zh) * 2007-07-27 2011-11-09 上海优拓医药科技有限公司 稳定型盐酸伊伐布雷定结晶及其制备方法
PT2471780E (pt) 2007-05-30 2015-02-24 Ind Swift Lab Ltd Sais oxalato de ivabradina cristalinos e seus polimorfos
CN102264689B (zh) 2008-12-22 2014-12-31 新梅斯托克尔卡公司 制备伊伐布雷定的方法
CN101768117B (zh) * 2008-12-29 2014-05-07 北京德众万全药物技术开发有限公司 一种盐酸伊伐布雷定晶型及其制备方法
CN101774969B (zh) 2009-01-13 2012-07-04 江苏恒瑞医药股份有限公司 硫酸伊伐布雷定及其i型结晶的制备方法
US8270169B2 (en) 2009-03-24 2012-09-18 Raytheon Company Translating hinge
WO2010128525A2 (en) 2009-05-04 2010-11-11 Dinesh Shantilal Patel A formulation of ivabradine for treating the cardiovascular disease
EP2534135A2 (en) 2010-02-12 2012-12-19 KRKA, D.D., Novo Mesto Novel forms of ivabradine hydrochloride
HUP1000245A2 (en) 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
WO2012025940A1 (en) 2010-08-25 2012-03-01 Cadila Healthcare Limited Polymorphic form of ivabradine hydrochloride and process for preparation thereof
CN102731400A (zh) * 2011-04-11 2012-10-17 山东新时代药业有限公司 一种盐酸伊伐布雷定的新晶型、制备方法及其在制备药物组合物中的用途
WO2013017582A1 (en) 2011-08-02 2013-02-07 Sandoz Ag Acetone solvate of ivabradine hydrochloride
EP2773621B1 (en) 2011-11-04 2015-12-30 Synthon BV A process for making crystalline delta-form of ivabradine hydrochloride
EP2589594A1 (en) * 2011-11-04 2013-05-08 Urquima S.A. Ivabradine hydrochloride Form IV
US9120755B2 (en) * 2011-11-14 2015-09-01 Cadila Healthcare Limited Polymorphic forms of ivabradine hydrochloride
CN103012269B (zh) * 2013-01-05 2014-08-13 江苏宇田生物医药科技有限公司 一种盐酸伊伐布雷定晶型c及其制备方法
WO2014114341A1 (en) 2013-01-24 2014-07-31 Synthon Bv Process for making ivabradine
SI2781509T2 (sl) 2013-03-19 2023-10-30 Chemo Research, S.L. Novi polimorf ivabradin hidroklorida in postopek za njegovo pripravo
CZ2013767A3 (cs) * 2013-10-02 2015-04-29 Zentiva, K.S. Pevná forma Ivabradin hydrochloridu a (S)-mandlové kyseliny a její farmaceutická kompozice
ES2672472T3 (es) 2013-12-12 2018-06-14 Synthon Bv Composición farmacéutica que comprende ivabradina amorfa
EP2774606B1 (en) 2014-02-14 2019-01-30 Synthon B.V. Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV
CN103880748B (zh) * 2014-04-03 2015-09-16 南京正大天晴制药有限公司 一种盐酸伊伐布雷定结构类似物及其制备方法和应用
CZ2014478A3 (cs) 2014-07-10 2015-09-16 Zentiva, K.S. Pevná forma Ivabradin hydrochloridu a (R)-mandlové kyseliny a její farmaceutická kompozice
WO2016102423A1 (en) 2014-12-22 2016-06-30 Ratiopharm Gmbh Composition comprising ivabradine in a dissolved form
CN105503726B (zh) * 2015-12-30 2019-07-30 浙江美诺华药物化学有限公司 伊伐布雷定盐酸盐晶型变体delta-d的制备方法
TR201703066A2 (tr) 2017-02-28 2018-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi İvabradi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari
EP3366282A1 (en) 2017-02-28 2018-08-29 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral pharmaceutical compositions of ivabradine
CN107200710A (zh) * 2017-05-22 2017-09-26 苏州华健瑞达医药技术有限公司 盐酸伊伐布雷定新晶型、制备方法及含有其的组合物
IT202000025312A1 (it) * 2020-10-26 2022-04-26 Cambrex Profarmaco Milano S R L Processi per la preparazione di polimorfi di ivabradina hcl

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0534859A1 (fr) * 1991-09-27 1993-03-31 Adir Et Compagnie 3-Benzazépin-zones substituées par un groupe benzocyclobutyl- ou indanyl-alkyl-amino-alkyle, utiles dans le traitement des affections cardiovasculaires
WO2006092491A1 (fr) * 2005-02-28 2006-09-08 Les Laboratoires Servier FORME CRISTALLINE βd DU CHLORHYDRATE DE L'IVABRADINE, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9017453D0 (en) 1990-08-09 1990-09-26 Mcivor Robert C Fluid additive regulating apparatus
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891826B1 (fr) * 2005-10-11 2007-12-28 Servier Lab Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0534859A1 (fr) * 1991-09-27 1993-03-31 Adir Et Compagnie 3-Benzazépin-zones substituées par un groupe benzocyclobutyl- ou indanyl-alkyl-amino-alkyle, utiles dans le traitement des affections cardiovasculaires
WO2006092491A1 (fr) * 2005-02-28 2006-09-08 Les Laboratoires Servier FORME CRISTALLINE βd DU CHLORHYDRATE DE L'IVABRADINE, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Also Published As

Publication number Publication date
NO20064588L (no) 2007-04-12
US20090318418A1 (en) 2009-12-24
MY140490A (en) 2009-12-31
PE20070547A1 (es) 2007-07-07
NZ550436A (en) 2007-12-21
BRPI0604253A (pt) 2007-08-21
CR8647A (es) 2007-06-08
NI200600240A (es) 2008-01-10
US20080227771A1 (en) 2008-09-18
IL178545A (en) 2017-04-30
FR2891827A1 (fr) 2007-04-13
AU2006228028A1 (en) 2007-04-26
EA200601661A1 (ru) 2007-04-27
CA2564369C (fr) 2010-06-15
JP2007112797A (ja) 2007-05-10
CO5840253A1 (es) 2007-12-31
US20070082886A1 (en) 2007-04-12
GEP20094654B (en) 2009-03-25
US7879841B2 (en) 2011-02-01
AU2006228028B2 (en) 2011-08-25
WO2007042657A1 (fr) 2007-04-19
SG131857A1 (en) 2007-05-28
UY29856A1 (es) 2006-11-30
CA2564369A1 (fr) 2007-04-11
EP1775287A1 (fr) 2007-04-18
UA90266C2 (ru) 2010-04-26
TW200800221A (en) 2008-01-01
CN1948293A (zh) 2007-04-18
KR20070040310A (ko) 2007-04-16
US7384932B2 (en) 2008-06-10
ECSP066914A (es) 2007-05-30
GT200600448A (es) 2007-05-21
AP2006003757A0 (en) 2006-10-31
EA010286B1 (ru) 2008-08-29
FR2891827B1 (fr) 2007-12-28
SA06270371B1 (ar) 2010-03-08
IL178545A0 (en) 2007-02-11
MA28625B1 (fr) 2007-06-01
MXPA06011767A (es) 2007-04-10
AR056573A1 (es) 2007-10-10
EP1958937A1 (fr) 2008-08-20
ZA200608404B (en) 2008-06-25

Similar Documents

Publication Publication Date Title
AP2185A (en) de, a process for its preparation and pharmaceuticDelta d crystalline form of ivabradine hydrochlorial compositions containing it.
IL178544A (en) Crystalline form - δ of ivabradine hydrochloride, process for preparation and pharmaceutical preparations containing it
AP2190A (en) Betad-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceuticalcompositions containing it.
ME02750B (me) Kristalni oblik gama - d iv abradin hlorhidrata, postupak njegove izrade i farmaceutske smeše koje ga sadrže
AP2006003521A0 (en) Y-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it.
ME01408B (me) Beta kristalni oblik ivabradin hidrohlorida, postupak njegove izrade i farmaceutske smeše koje ga sadrže
LT2210872T (lt) Nauja kristalinė aglometino forma iii, jos gamybos būdas ir ją turinčios farmacinės kompozicijos
ME02026B (me) Novi kristalni v oblik agomelatina, postupak za njegovu proizvodnju i farmaceutske smiješe koje ga sadrže
HK1096386A1 (en) Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200603810B (en) Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
HK1096097A1 (en) Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
AU2006200857B2 (en) y-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
AU2006200854B2 (en) bd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it